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The proteins of the Dbl family are guanine nucleotide exchange factors (GEFs) of Rho GTPases and are known to be
involved in cell growth regulation. Alterations of the normal function of these proteins lead to pathological processes
such as developmental disorders, neoplastic transformation, and tumor metastasis. We have previously demonstrated
that expression of Dbl oncogene in lens epithelial cells modulates genes encoding proteins involved in epithelial-
mesenchymal-transition (EMT) and induces angiogenesis in the lens. Our present study was undertaken to investigate
the role of Dbl oncogene in epithelial cells transformation, providing new insights into carcinoma progression.To assess
how Dbl oncogene can modulate EMT, cell migration, morphogenesis, and expression of pro-apoptotic and angiogenic
factors we utilized bi- and 3-dimensional cultures of MCF-10 A cells. We show that upon Dbl expression MCF-10 A cells
undergo EMT. In addition, we found that Dbl overexpression sustains Cdc42 and Rac activation inducing morphological
alterations, characterized by the presence of lamellipodia and conferring a high migratory capacity to the cells.
Moreover, Dbl expressing MCF-10 A cells form altered 3D structures and can induce angiogenesis by producing
proangiogenic factors such as CCL2. These results support a role for Dbl oncogene in epithelial cell differentiation and
transformation and suggest the relevance of GEF deregulation in tumor onset and progression.
Introduction
Epithelial-mesenchymal-transition (EMT) is a fundamental
biological process by which epithelial cells are transdifferentiated
to a mesenchymal state, and is a normal process during embry-
onic development and wound healing. EMT has also been impli-
cated in cancer progression, metastasis and invasion.1,2 It begins
with the loss of apico-basal polarity, degradation of basement
membrane, decrease in epithelial-specific gene expression, includ-
ing E-cadherin, and acquisition of mesenchymal characteristics,
including expression of a-smooth muscle actin (a-SMA) and
metalloproteinases. Moreover, cells undergo changes in their
cytoskeleton, which enable them to acquire the ability to migrate
and invade.3-5 EMT modulates the tumor microenvironment by
inducing the upregulation and the secretion of several soluble fac-
tors, including angiogenic factors and cytokines, that may induce
proliferation of endothelial cells, resulting in neovascularization.6
The Dbl protein is the prototype member of a large family of
guanine nucleotide exchange factors (GEFs) for Rho GTPases,7-9
which are known to regulate various physiological processes includ-
ing actin cytoskeleton organization, cell movement, cell prolifera-
tion, cytokinesis, and apoptosis.10-12 The Dbl oncogene was shown
to have a strong transforming activity in fibroblasts,13 to affect den-
drite elongation in a mouse knock-out model 14 and to induce B-
cell lymphomas in a mouse knock-in model.15 Moreover, expres-
sion of the Dbl oncogene under the metallothionein promoter in
transgenic mice affects proliferation, migration, and differentiation
of lens epithelial cells.16 We have defined the cluster of genes that
are induced or inhibited in the lenses of Dbl transgenic mice at sev-
eral time points after birth.17 Results obtained indicate modulation
of genes encoding proteins involved in EMT, apoptosis, and vascu-
logenesis, suggesting that Dbl oncogene expression in lens epithelial
cells can induce events involved in the early stages of cancer, such as
aberrant proliferation, block of differentiation and apoptosis, as
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well as late events such as EMT, disruption of the basal membrane,
and neovascularization.
To further characterize the role of Dbl oncogene in epithelial
cancer onset and progression we have analyzed the effects of the
Dbl oncogene expression in MCF-10 A epithelial cell line.
MCF-10 A are immortalized, non-transformed epithelial cells
derived from human fibrocystic mammary tissue. MCF-10 A
cells retain the intrinsic ability of mammary epithelial cells to
undergo acinar morphogenesis in 3D matrigel cultures, a process
that relies on growth factor-dependent proliferation, induction
of luminal programmed cell death, establishment of an apico-
basal polarity axis, and the deposition of a basal lamina.18 Vari-
ous oncogenes can have distinct perturbing effects on acinar mor-
phogenesis and can induce supra-cellular effects in the cell
colonies.19
We report here that Dbl expressing MCF-10 A cells cultured
in matrigel form altered hollow, 3D structures characterized by
reduced lumen size, almost complete lack of cleaved-caspase 3
expression and high expression of Ki-67, denoting active
proliferation. Moreover, we show that the MCF-10 A cells
expressing Dbl oncogene stimulates the invasion and the tube
formation potencies of Human Umbilical Vein Endothelial Cells
(HUVECs) and that this proangiogenic activity is mediated by
CCL2 secretion. In conclusion, our data support a role for Dbl
oncogene in epithelial cell differentiation and transformation and
in the induction of neovascularisation by stimulating the produc-
tion of proangiogenic factors.
Results
Dbl oncogene induces EMT in mammary epithelial
MCF-10 A cells
EMT leads to aggressive cancer progression and implies the
loss of epithelial markers, such as E-cadherin, increased cell
motility and expression of mesenchymal genes, such as a-SMA
and MMP.20
To determine the role of Dbl in governing EMT in human
mammary epithelial cells, MCF-10 A cells were infected with a
Figure 1. EMT induction by Dbl oncogene. (A) qRT-PCR analysis of genes involved in EMT. 2 mg of total RNA were reverse-transcribed and qRT-PCR was
conducted in triplicate for each target transcript. Expression changes of genes were evaluated in relation to the values obtained in parallel for 2 reference
genes. The average results from 3 independent experiments were calculated and represented. The mean values ( § SD) are indicated. *P < 0.05; ***P <
0.001. (B) Confirmation of qRT-PCR analysis by Western Blot. Total cell lysates from pRed and pRDbl cells were blotted with anti-E-cadherin, anti-a-SMA
and anti-MMP12 antibodies. Actin was used as a loading control. Representative photomicrographs are shown. (C) The optical density of the films was
scanned and measured and the average results from 3 independent experiments were calculated and represented; *P < 0.05; **P < 0.005; ***P < 0.001.
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lentiviral vector expressing Dbl onco-
gene fused to the fluorescence Red epi-
tope (pRDbl) or with the control
lentivirus (pRed) and cultured for 2
weeks under puromycin selection.
pRDbl and control pRed cells were
lysed and E-cadherin, a¡SMA and
MMP-12 transcripts were quantified by
RT-qPCR. Fig. 1A shows the relative
mRNA expression levels of selected
genes in pRDbl respect to pRed cells. A
considerable downregulation of E-cad-
herin and upregulation of a-SMA and
MMP-12 transcripts was triggered by
the expression of Dbl oncogene in
MCF-10 A cells. Cell lysates from
pRDbl and pRed MCF-10 A cells were
analyzed by Western blotting with anti-
E-cadherin, anti-a¡SMA, and anti-
MMP-12 antibodies. The RT-qPCR
results were confirmed by protein
expression analysis (Fig. 1B and 1C).
Dbl oncogene alters MCF-10 A
monolayer morphology and motility
Cells that undergo EMT reorganize
their cortical actin cytoskeleton into
one that enables dynamic cell elonga-
tion and directional motility.21 Thus,
we investigated whether the expression
of pRDbl causes changes in MCF-10 A
cell morphology (Fig. 2A). Phase con-
trast images showed that cells infected
with pRed vector adopt a cobblestone
morphology (a0), typical of mammary
epithelial cells, with some lamellipodia
at the edges of the clusters (c0, e0 and
g0). On the contrary, pRDbl cells are
characterized by an enlarged and polyg-
onal cell shape (b0), and increase in
membrane ruffling and lamellipodia
formation (d0, f0 and h0). About 20% of
MCF-10 A cell population expressing
Dbl oncogene is constituted by giant
multinucleated cells, a morphology
originally described for Dbl-transformed NIH3T3 cells.22,23
These cells seem to originate as a result of several cycles of nuclear
division with no apparent cytokinesis.23
To better visualize the differences observed in phase contrast
images, pRDbl and the control cells were plated on glass cover-
slips and treated with anti-Red to detect Dbl and vector alone,
and with FITC-labeled phalloidin to detect actin. Nuclei were
visualized with DAPI (Fig. 2B). The expression of pRDbl in
MCF-10 A cells induces evident cell body enlargement and an
increase in the extension of the ruffles and lamellipodia compared
to pRed infected cells, which maintain their epithelial cell
morphology. Dbl protein was mostly localized on the membrane
at the ruffling sites (Fig. 2B, arrowheads), in agreement with the
knowledge that activated Dbl protein translocates to the plasma
membrane where it exerts its GEF activity.24
The regulation of cytoskeletal changes associated with
migratory behavior of cells is dependent on Rho GTPase
activity.25 In fact, Rho GTPases play a crucial role in the
actin cytoskeleton rearrangements, cell motility, and cell–cell
dissociation associated with EMT.26,27 Therefore, we investi-
gated whether the morphological changes observed in pRDbl
MCF-10 A cells could be correlated with activation of small
Figure 2. Dbl oncogene expression alters MCF-10 As monolayer morphology. (A) Phase-contrast
images of pRed (a0 , c0 , e0 and g0) and pRDbl (b0 , d0 , f0 and h0) cells cultured to confluence or sub-con-
fluence in assay media. Magnification: 4X (a0 , b0 , c0 , d0); 20X (e0 , f0); 40X (g0 , h0). (B) Immunofluorecence
analysis of the distribution of pRDbl oncoprotein. pRed and pRDbl cells grown on glass coverslips,
were fixed, permeabilized and stained for actin filaments, using FITC-conjugated phalloidin (green),
and for nuclei, using DAPI (blue). pRDbl cells show a polygonal shape, and the red fluorescence signal
mostly diffused in the cytoplasm and partially localized on the plasma membrane. In contrast, pRed
cells appear elongated, and the red signal diffused in the cytoplasm, with no localization along the
plasma membrane. The actin cytoskeleton (green) is organized in well-evident short stress fibers and
some ruffling and lamellipodia in cells expressing pRDbl, and in thin, long stress fibers in pRed
expressing cells. Arrowheads indicate the ruffling and lamellipodia areas of the plasma membrane
where the DbI protein localizes, arrows indicate stress fibers. Scale bar: 10 mm.
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G proteins by Dbl oncogene. Lysates obtained from cells
infected with pRDbl or the control vector were subjected to
a pulldown assay. Endogenous, activated Cdc42 and Rac
were collected on GST-PAK-CRIB domain fusion protein
and analyzed by Western blot. As
shown in Fig. 3A, the levels of the
GTP-bound forms of Cdc42 and
Rac increase in pRDbl cells in com-
parison with pRed cells. We also
evaluated active RhoA-GTP by an
absorbance based method and found
that expression of pRDbl induces
RhoA activation (Fig. 3B).
EMT is characterized by an
increased cell capacity for migration
and invasion.4 Activation of Cdc42
and Rac results in the formation of
filopodia and lamellipodia, respec-
tively, and the formation and turnover
of these structures are important in
cell migration. We performed a trans-
well assay at different time points to
evaluate whether the activation of Rac
and Cdc42 in pRDbl cells correlated
with cell migration.
As shown in Fig. 3C, pRDbl cells
migrate better than control pRed cells.
Dbl regulation of cell motility through
activation of Rac was confirmed by
treatment of pRed and pRDbl MCF-
10 A cells with the Rac GTPase-spe-
cific inhibitor NSC23766.28 As shown
in Fig. 3D the presence of NSC23766
inhibits pRDbl cell migration but
does not affect the motility of control
cells. We performed a pulldown assay
to evaluate the inhibitory effect of
NSC23766 on Dbl-stimulated Rac
activity in vivo. Treatment of pRDbl
MCF-10 A cells with 100 mM
NSC23766 resulted in inhibition of
Rac-GTP compared to untreated cells
(Fig. 3E).
To evaluate whether the induction
of EMT correlates with the transform-
ing capacity of Dbl oncogene we per-
formed a soft agar colony formation
assay. Fig. 4 A and B showed a signifi-
cant increase in anchorage-indipend-
ent growth in comparison with pRed
MCF-10 A cells. Altogether, these
results indicate that Dbl oncogene-
induced activation of Rho GTPases in
MCF-10 A cells stimulates cell migra-
tion and promotes transformation.
Dbl oncogene affects epithelial cell
morphogenesis
The spontaneously immortalized and non-tumorigenic MCF-
10 A epithelial cells possess 3 dimensional (3D) growth ability
Figure 3. Dbl oncogene mediates cell motility. (A) In vivo GEF activity of Dbl oncogene on small G pro-
teins Cdc42 and Rac. pRed and pRDbl cells, serum-starved for 18 hr, were lysed and subjected to the
Cdc42 and Rac activation assays. Eluates from GST-PAK precipitates or total cell lysates were subjected
to immunoblotting with anti-Cdc42 and anti-Rac antibodies. Specific Dbl product was detected using
anti Dbl antibody. Results from one of 3 independent experiments is shown as representative. (B) Cell
lysates were subjected to an absorbance based activation assay for RhoA. Results shown represent the
mean values § SD from 3 different experiments. Protein expression level was evaluated by Western
blot analysis with specific antibodies using total cell lysates. (C) pRed and pRDbl cells were subjected
to a transwell migration assay as described in "Materials and methods." Briefly, cells resuspended in
serum-free medium were seeded on the upper chamber. Inserts were incubated for 1, 2, and 4 h and
cells on the underside of the insert were fixed and stained with May–Grunwald/Giemsa. Representa-
tive photomicrographs are shown (magnification: 20X for 1 and 2 hours, 4X for 4 hours). (D) Cell
migration was assayed on pRed and pRDbl MCF-10 A cells cultured overnight in the absence or pres-
ence of 100 mM of NSC23766. The average results from 3 independent experiments were calculated
and represented. ** P < 0.01. (E) pRed and pRDbl cells cultured overnight in the absence or presence
of 100 mM of NSC23766 were lysed and subjected to the Rac activation assays.
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and form a polarized structure surrounding a hollow lumen. In
this process, proapoptotic genes or tumor suppressor genes pro-
mote, whereas oncogenes block, acinar differentiation. In fact,
oncogenes introduced in MCF-10 A cells disrupt this morphoge-
netic process, and elicit distinct morphological phenotypes.29-31
We evaluated the effects of Dbl expression on MCF-10 A cell
mophogenesis. Stable pools of MCF-10 A cells expressing Dbl
oncogene were cultured on a reconstituted basement membrane
gel (Matrigel) for 7–15 days. This assay was carried on for differ-
ent lengths of time to evaluate differences in proliferation capac-
ity between Dbl-expressing and parental cell lines. As shown in
Fig. 5A, Dbl structures displayed varying degrees of morphologi-
cal disruption and changes in overall structure size. The average
diameter of structures from Dbl expressing cultures was 140 §
17 mm (mean § SD) versus 90 § 13:8 mm (mean § SD) in
controls (Fig. 5B). Larger size and morphological alteration of
structures were apparent as early as day 7 in 3D culture and pro-
gressively increased thereafter.
We then analyzed the expression of the proteins involved
in EMT such as E-cadherin and a¡SMA during morphogen-
esis. pRed acini exhibited well-defined cell-cell junctions,
illustrated by membrane localization of E-cadherin,
concentrated toward the basal pole of the lateral membrane
(Fig. 6). Although in pRDbl acini E-cadherin initially dis-
played a membrane localization similar to that exhibited in
the control acini, (data not shown) during the second decade
of morphogenesis immunostaining was diminished and
became diffusely localized, indicating loss of E-cadherin at
adherens junctions. Mislocalization and loss of E-cadherin at
cell-cell junctions is an early event that is essential for EMT.
On this basis, we investigated whether Dbl expression pro-
motes EMT in 3D culture system by immunostaining the
acini with an antibody anti the mesenchymal marker
a¡SMA. As shown in Fig. 6 Dbl expression causes a consid-
erable increase in a-SMA expression vs. control cells.
Collectively, these data indicate that Dbl expression alters aci-
nar morphogenesis, leading to large, misshapen structures and
multiacinar formations, and induces downregulation of epithelial
markers and upregulation of fibroblast markers suggesting that
Dbl activation promotes EMT.
Dbl expression prevents luminal apoptosis during
morphogenesis
Apoptosis is involved in the elimination of centrally located
cells during lumen formation in MCF-10 A acini and in the
maintenance of the hollow lumen thereafter. When oncoproteins
such as ErbB2 are expressed in these structures, the lumen is filled
because of induction of cell proliferation and inhibition of apo-
ptosis.29,32 To study the effect of Dbl expression on apoptosis in
the luminal space of mammary structures during morphogenesis,
stable pools of MCF-10 A cells expressing Dbl oncogene were
cultured on a reconstituted basement membrane gel (Matrigel)
for 10 days. 3D structures were then examined for filled lumen
by immunostaining with an antibody against the cleaved, acti-
vated form of caspase 3. Fig. 7 shows a significant filling of the
luminal space and reduced apoptosis, as demonstrated by the
almost complete lack of cleaved-caspase 3 expression in the
lumen of pRDbl-expressing MCF-10 A acini compared with
control structures.
Next, we examined the effects of Dbl expression on cell prolif-
eration during morphogenesis by immunostaining for Ki-67, a
marker of cycling cells as well as EMT.33 We observed that
pRDbl-expressing MCF-10 A acini exhibit high levels of Ki-67
positive cells during morphogenesis (Fig. 7), indicating that inhi-
bition of cell death and increased cell proliferation account for
the increased size and filled lumens of pRDbl MCF-10 A acini.
Dbl oncogene induces endothelial cell migration
Tumor cells undergoing EMT are known to increase the
secretion of specific factors, including cytokines, chemokines,
and growth factors, which play an important role in inducing
angiogenesis and tumor progression.6
We examined whether pRDbl cells secrete factors that
induce endothelial cell migration. HUVECs were co-cultured
with pRDbl MCF-10 A cells and migration was evaluated
by scratch wound healing assays. As shown in Fig. 8 A and
B, pRDbl cells co-cultured in conditioned medium increased
Figure 4. Dbl oncogene induces anchorage independent growth of
MCF-10 A cells. pRed and pRDbl MCF-10 A cells were cultured as indi-
cated in "Materials and methods." Colonies were scored after 14 days
and photographed. (A) Representative photomicrographs are shown.
(magnification: 4X) (B) The colony number was quantified from 3 inde-
pendent soft agar assays. *** P< 0.001.
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endothelial cell migration by up to 25% compared to the
control.
Dbl oncogene can promote neovascularisation in the lens
by upregulating proangiogenic factors, such as CCL2/MCP-
1.17 On this basis, we evaluated whether MCF-10 A cells
expressing Dbl synthesize and secrete the chemokine CCL2/
MCP-1. Fig. 9A shows a significant upregulation of CCL2
mRNA in MCF-10 A cells expressing Dbl oncogene vs con-
trol. The initial phase of angiogenesis involves organization
of individual endothelial cells into a 3-dimensional pseudo-
capillary-like structure. Therefore, we evaluated whether
secreted CCL2 could stimulate formation of capillary-like
structures.34 HUVECs, plated in a thin layer of Matrigel,
were co-cultured with pRed or pRDbl MCF-10 A cells and
the number of intact ring that HUVECs are able to form
was determined. HUVECs, cultured with pRDbl MCF-10 A
cells, organized into a network of pseudo-capillary tubes that
invaded the gel (Fig. 9B, b0; Fig. S1, b0). Quantification of
the number of circles formed by tubular HUVECs highlights
the significant increase of capillary tube formation induced
by pRDbl cells versus that induced by co-culture with pRed
MCF-10 A cells (Fig. 9C). Further-
more, HUVECs co-cultured with
pRDbl MCF-10 A cells in the pres-
ence of 1 mg/ml CCL2 blocking
peptide failed to form capillary tubes
(Fig. 9B, d0; Fig. 9C; Fig. S1 d0),
indicating that Dbl oncogene expres-
sion in MCF-10 A cells controls
CCL2/MCP-1 output and the
angiogenic phenotype.
Discussion
TheDbl oncogene was originally iso-
lated from a human B-cell lymphoma
and the mammary carcinoma cell line
MCF-7 as 2 activated versions of the
same proto-oncogene.22,35 Dbl protein
is the prototype of the large family of
GEFs for Rho GTPases Cdc42, RhoA
and Rac. GEFs are involved in cell
growth regulation and play an essential
role in establishing epithelial cell polar-
ity. Dbl expression in mammary epithe-
lial cells has been previously linked to
transformation and stimulation of
motility.36-38
In this work we provide evidence
that Dbl oncogene causes morphologi-
cal changes, increases migratory behav-
ior, and promotes transformation of
MCF-10 A cells. Cells expressing Dbl
also exhibit increase in Cdc42, Rac,
and Rho activation in the absence of
growth factor stimulation, compatible with the constitutive acti-
vation of GTPase exchange activity of Dbl oncogene. Moreover,
the expression of Dbl oncogene in MCF-10 A epithelial cells acti-
vates downstream effectors to induce EMT-like processes and to
stimulate angiogenesis.
During EMT, the decrease in epithelial characteristics is indi-
cated by the decreased expression of E-cadherin, which downre-
gulates epithelial cell migration, and is accompanied by the
acquisition of mesenchymal features, including the expression of
a¡SMA and MMPs.39 Our results indicate that Dbl expression
not only induces morphological transformation of MCF-10 A
but also makes these cell to undergo EMT, leading to the down-
regulation of epithelial-specific markers, like E-cadherin, upregu-
lation of mesenchymal markers, such as a¡SMA, and induction
of expression of EMT markers, such as Ki-67 and MMP-12, all
concurrently contributing to the cytoskeleton alterations and
increased motility.40
Angiogenesis, essential for physiological as well as pathological
conditions, including tumor growth and metastasis, is a complex
multistep process that includes endothelial cells proliferation,
migration, and differentiation of endothelial cells, degradation of
Figure 5. Dbl oncoprotein affects acinar structures. (A) Phase-contrast images illustrate the develop-
ment of acinar structures in pRed and pRDbl cells at 7 (7 d) and 15 (15 d) days. Scale bar: 100 mm. (B)
The mean ( § SD) diameters of pRed and pRDbl acini after the indicated days in basement membrane
culture are shown. **P< 0.01.
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extracellular matrix, microtubule forma-
tion, and sprouting of new capillary
branches.41 Although activated onco-
genes increase tumor cell proliferation
and decrease their apoptosis, these activi-
ties are not sufficient to expand tumor
mass beyond a microscopic size. Induc-
tion of angiogenesis is a necessary step
for expansion of tumor mass. In this
respect, EMT not only increases tumor
cell migration and invasion, but also
promotes tumor angiogenesis by induc-
ing expression of angiogenic factors and
cytokines.42
Indeed, we show that the expression
of Dbl oncogene in MCF-10 A cells
causes upregulation of the pro-angio-
genic factor CCL2/MCP-1 that
increases endothelial cell migration and
ability to form a network of pseudoca-
pillary tubes. CCL2 is a potent angio-
genic chemokine that acts directly on
endothelial cells to promote angiogene-
sis.43,44 Moreover, CCL2 is highly
expressed by breast tumor cells and has
causative roles in breast malignancy
and metastasis.45
During normal acinar morphogene-
sis, lumen formation involves both the block of proliferation and
the apoptosis of centrally localized cells that are not in contact
with the basement membrane.29 The 3D MCF-10 A cultures
provide a model that can be useful to determine the pathways
that regulate acini structure formation as well as to identify genes
and pathways that induce phenotypic alterations similar to those
associated with tumor progression, such as filling of the luminal
space, loss of polarization, escape from proliferative suppression,
invasive behavior, and loss of cell adhesion.46
Filling of the luminal space occurs when increase in cell prolif-
eration is associated with inhibition of apoptosis, either because
of expression of anti-apoptotic genes or because of expression of
oncogenes with anti-apoptotic activities. For example, activated
ErbB2 impinges on multiple aspects of acini development by dis-
turbing mechanisms that establish cell polarity, inducing a com-
plex multiacinar phenotype, increasing of cell proliferation,
filling of the luminal space, and protection from apoptosis, all
properties comparable to those of early stage cancer.32,47
Dbl-expressing MCF-10 A cells form altered hollow, multi-
acinar 3D structures characterized by filled lumen, an almost
complete lack of cleaved-caspase 3 expression and high expression
of Ki-67, indicating that Dbl oncogene provides significant pro-
tection of cells within the lumen from apoptosis and enhances
proliferation, thus overcoming the signals causing proliferative
arrest.
In summary, Dbl oncogene expression in MCF-10 A cells
induces some of the changes that characterize tumor progression.
In fact, we observed downregulation of E-cadherin, the lack of
which is implicated in the loss of cell-cell adhesion,48 and upre-
gulation of mesenchimal markers such as a-Sma, characteristics
of EMT, with consequent changes in cell morphology and cyto-
skeleton organization. Moreover, Dbl oncogene induces expres-
sion of MMP-12, one of the metalloproteinases that, because of
their extracellular matrix degrading activity, exert a pro-invasive
action,49 disruption of glandular structure, inhibition of anoikis
and stimulation of proliferation,50 hallmarks of epithelial tumors.
Finally, Dbl stimulates the expression of the pro-angiogenic fac-
tor CCL2, necessary for the outgrowth of new vessels, essential
for tumor growth and metastasis.
The identification of a new regulatory loop between angiogen-
esis and EMT in Dbl-transformed epithelial cells represents a
novel step forward in understanding the mechanisms and the rel-
evance of GEF deregulation in tumor onset and progression.
Material and Methods
Antibodies, reagents, inhibitors
Polyclonal antibody anti-Dbl was purchased from Santa Cruz
Biotechnology. Polyclonal antibody anti-DsRed was purchased
from Clontech. Monoclonal antibody against Rac was purchased
from Upstate Biotecnology. Polyclonal antibody against Cdc42
was purchased from BD Transduction Laboratories. Mouse
monoclonal antibody against RhoA was purchased from Santa
Cruz Biotechnology. Monoclonal antibody against a-SMA was
purchased from DAKO. Polyclonal antibody against Cleaved
Figure 6. Dbl oncogene induces loss of proliferative suppression and luminal apoptosis. Acini cul-
tured for 10 days in Matrigel were fixed and immunostained with antibodies against Red epitope
(red), E-cadherin (green) and a-SMA (green). Nuclei were counterstained with DAPI (blue). Scale bar:
20 mm.
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Caspase-3 was purchased from Cell Signaling. Rabbit monoclo-
nal anti MMP-12 was purchased from Novus Biologicals. Mouse
monoclonal anti human E-cadherin was kindly provided by Dr.
Defilippi (MCB, University of Turin). CCL2 blocking peptide
was purchased from Fitzgerald Industry International. Rac
GTPase inhibitor NSC23766 was kindly provided by Dr. Y.
Zheng.
Cell cultures
MCF-10 A cells, an immortalized, non-transformed epithelial
cell line derived from human fibrocystic mammary tissue, were
kindly provided by Dr. Defilippi (University of Turin). MCF-10
A cells were maintained in DMEM/F12 (Gibco) supplemented
with 5% horse serum, 20 ng/ml EGF, 10 mg/ml insulin,
0.1 mg/ml cholera toxin, 0.5 mg/ml hydrocortisone, 50 U/ml
penicillin and 50mg/ml streptomycin. Human Umbilical Cord
Vein Endothelial Cells (HUVECs) were from Cambrex. Cells
were maintained in basal EGM-2 supplemented with 10% FBS
(Hyclone).
Lentivirus Production
The pLVX-DsRed-Monomer-C1 vector (Clontech) was uti-
lized to obtain a lentiviral construct expressing Dbl conjugated
with a red fluorescent protein. Recombinant lentiviruses were
produced in HEK-293 T cells using the Lenti-X Lentiviral
Expression kit (Clontech) as described by the manufacturer.
MCF-10 A cells were infected with lentiviruses expressing the red
fluorescent protein alone (pRed) or the Dbl product fused to the
red fluorescent protein (pRDbl) in the
presence of 10 mg/ml of polybrene.
pRed and pRDbl infected cells were
cultured in DMEM/F12 supplemented
with 5% horse serum and 40 mg/ml
puromycin.
In vivo Rho GTPases activation
assay
Pull-down assays were carried out as
previously described.51 Briefly, gluta-
thione-coupled Sepharose 4B beads
bound to recombinant GST–PAK
CRIB domain fusion protein were
incubated with cell extracts at 4C for
45 min, eluted in Laemmli buffer and
analyzed for the presence of Rac1 and
Cdc42 by Western blot.
Activated RhoA was detected by
using a G‑Lisa RhoA Activation assay
(Absorbance based) (Cytoskeleton Inc.)
as indicated by the manufacturer. Ali-
quots of cell lysates were subjected to
SDS PAGE and immunoblotting to
evaluate pRDbl and RhoA expression
levels.
Western Blot analysis
pRed and pRDbl cells were lysed in StaphA buffer containing
1 mM AEBSF and 10 mg/ml each of aprotinin and leupeptin.
Lysates were separated by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) and transferred to PVDF mem-
brane (Merck Millipore). Lysates were probed with specific anti-
bodies to detect E-cadherin, a-SMA, MMP-12 and Dbl
expression level. The blots were reprobed with anti-b-actin
(Santa Cruz) antibody to evaluate protein loading. Immunocom-
plexes were visualized by West Dura extended chemiolumines-
cent detection using a horseradish peroxidase (HRP)-conjugated
secondary antibody (Thermo Fisher Scientific). The optical den-
sity of the film was scanned and measured with Quantity One v.
2–3 Image software (Versa Doc, Biorad).
Real-Time quantitative (qRT)-PCR analysis
Total RNA was purified using the RNeasy MiniKit from Qia-
gen, and controlled for integrity with an Agilent Bioanalyzer
2100 (Agilent Technologies). RNA was quantified by NanoDrop
(NanoDrop Technologies) and reverse-transcribed into double-
stranded cDNA on a GeneAmp PCR System 2700 thermal cycler
(Applied Biosystems) using the SuperScript Double-Stranded
cDNA synthesis kit (Invitrogen). qRT-PCR was performed on a
7500 Real Time PCR System (Applied Biosystems) in triplicate
for each target transcript using SYBR Green PCR Master Mix
(Applied Biosystems) and sense/antisense oligonucleotide pri-
mers (Table 1) synthesized by TIB Molbiol (Genova, Italy) as
detailed.52 Expression data were normalized on the values
obtained in parallel for 2 reference genes (Actin Related Protein
Figure 7. Dbl expression prevents luminal apoptosis during morphogenesis. Acini were cultured in
Matrigel for 10 days, fixed and immunostained with antibodies against Red epitope (red), activated
caspase-3 (green), and Ki-67 (green). Nuclei were counterstained with DAPI (blue). Scale bar: 20 mm.
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2/3 Complex subunit 1, ARPC1B;
ribosomal protein S19, RPS19) using
the Bestkeeper software, and relative
expression values were calculated using
Q-gene software.52 Data were ana-
lyzed with Graph Pad Prism 5 soft-
ware v. 5.00 (GraphPad Software).
Cell migration
Cell migration was assayed in Boy-
den chambers (8.0 mm pore size,
FALCON cell culture insert). pRed
and pRDbl MCF-10 A cells were cul-
tured overnight in the absence or pres-
ence of 100 mM of NSC23766. The
cells were trypsinized and counted.
One £ 105 cells were resuspended in
serum‑free medium and added to the
upper chamber. Inserts, previously
coated with fibronectin on the lower
side, were incubated for 1, 2 and 4 h
at 37C with 700 ml of complete
medium in the lower chamber. Cells
on the inside of the inserts were
removed with a cotton swab, and cells
on the underside of the insert were
fixed and stained with May‑Grun-
wald/Giemsa. The number of cells
were counted and the average number
of the cells that had transmigrated was
determined.
For the scratch assay, pRed or
pRDbl (8 £ 104) cells were plated on
transwell inserts (12 mm diameter,
polycarbonate membranes with
0.4 mm pores, Corning, Lowell, MA,
USA) and cultured to confluence.
HUVECs were plated in 12-well
plates at the concentration of 8 £ 104
cells/well and cultured to 90% conflu-
ence in EGM-2 medium supple-
mented with 10% FBS. HUVECs
were then starved for 24 h in EGM-2
medium containing 0.1% FBS. Cell
monolayers were then scored vertically
down the center of each well with a
sterile tip and each well was washed
with PBS to remove detached cells.
Medium was replaced with fresh
EGM-supplemented with 0.1% FBS.
The transwell inserts containing pRed
or pRDbl cells were then placed on
top of HUVECs and cultured for
another 24 h.
Images of the wound in each well
were acquired at time 0 (t0) and after
Figure 8. Dbl expression induces endothelial cell migration. (A) HUVEC migration was evaluated by
the scratch assay. Representative images of healing in the presence of MCF-10 pRed or pRDbl at 0 and
24 h (t D 0 and t D 24) are reported (magnification: 10X). (B) Data are reported as a percentage of
area covered by endothelial cells (EC) after co-culture with MCF-10 pRed or pRDbl. The experiment
was performed 3 times in duplicate (2 wells/experiment). Cells were photographed and cell-free areas
were measured by image analysis. *P < 0.05.
Figure 9. CCL2 stimulates pseudocapillary tube formation. (A) qRT-PCR analysis of CCL2 gene. 2 mg of
total RNA were reverse-transcribed and qRT-PCR was conducted in triplicate. Expression changes of
genes were evaluated in relation to the values obtained in parallel for 2 reference genes. The mean
values ( §SD) are indicated. *P < 0.05. (B) Endothelial cell organization on Matrigel in the co-culture
system with pRed or pRDbl MCF-10 A. HUVECs were seeded on Matrigel layers and maintained for
18 h in the presence of pRed (a0 ,c0) or pRDbl MCF-10 A(b0 ,d0) cells. Where indicated 1 mg/ml of CCL2
blocking peptide (CCL2-BP) was added (c0 ,d0). Scale bar: 100 mm. (C) Data in the graph are reported as
angiogenic index, calculated as the number of complete circles counted/field at 4X magnification by
image analysis. ##P < 0.01 **P < 0.05.
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24 h (t24) under phase contrast microscope at the magnification
of 10X. The area covered by the cells was measured by using
Image J and the ratio between t24 and t0 was performed. Results
are expressed as percentage of healing taking as reference the area
at time 0.
Anchorage-independent growth assay
For soft agar assay, cells were detached from plates, resuspended
in DMEM/F-12 medium with 5% HS and 0.3% agarose (Ultra-
PureTM by Invitrogen), and plated on top of a 0.5% agarose layer
at the concentration of 104 and 105 cells per plate. Cells were fed
once a week with DMEM/F-12 supplemented with 5% HS and
growing colonies were scored after 14 days and photographed.
Three-dimensional morphogenetic assay
3D morphogenetic assays were conducted as previously
described in http://muthuswamylab.cshl.edu/ml protocols.html
and for a review see refs.30,53,54
Immunofluorescence analysis
pRed and pRDbl cells were plated onto glass coverslips, fixed
with 4% paraformaldehyde in PBS for 30 minutes at 25C,
treated with 0.1 M glycine in PBS for 20 minutes at 25C and
with 0.1% Triton X-100 in PBS for additional 5 minutes at
25C to allow permeabilization. Filamentous actin was visualized
by incubating the cells with FITC-labeled phalloidin (Sigma) in
PBS for 45 min at 25C, and nuclei were stained with 10 mg/ml
DAPI (Sigma). Coverslips were mounted with Mowiol (Calbio-
chem) for observation.
To analyze 3D acinar structures, immunostaining of 3D cul-
tured MCF10 A cells was performed as described in http://
muthuswamylab.cshl.edu/protocols/IF protocol.pdf
Fluorescence signals were visualized with an AxioObserver
inverted microscope (Zeiss), equipped with the ApoTome Sys-
tem (Carl Zeiss Inc.). In the case of active caspase 3 and Ki-67
cells were scanned in a series of 0.5 mm sequential sections with
an ApoTome System (Zeiss), connected to an AxioObserver
inverted microscope; images were all acquired by the digital cam-
era Axio CAM MRm (Zeiss) and analysis was performed by the
Axiovision software (Zeiss). Reconstruction of a selection of 3
central out of the total number of the serial optical sections was
shown in each figure. Red epitope was visualized by incubating
cells with Anti-Red antibody (Clontech).
Matrigel assay
pRed or pRDbl MCF-10 A cells (8 £ 104) were cultured on
transwell inserts (12 mm diameter, polycarbonate membranes
with 0.4 mM pores, Corning,) to confluence. The inserts were
placed on top of HUVECs plated in 12-well plates at 13.5 £ 104
cells/well onto a thin layer (300 ml) of basement membrane
matrix (Matrigel; Becton Dickinson) in EGM-2 medium supple-
mented with 0.1% FBS. In some experiments 1 mg/ml of CCL-2
blocking peptide was added to the lower chamber. After 18 h,
the transwells and the medium were removed and HUVECs
were fixed with 4% paraformaldehyde in PBS for 30 min at
25C and permeabilized with 0.1% Triton X‑100 for 5 min. Fil-
amentous actin was visualized by incubating the cells with
DY554 phalloidin (Thermo Fisher Scientific). Images of fluores-
cent cells were obtained using a Nikon Eclipse TE 300 inverted
microscope and acquired by a Nikon digital camera DS-5 MC
and NIS Element software (Nikon). Quantification of the tubu-
lar structures was performed by counting the number of complete
circles produced by interlinking tubular HUVECs.55
Statistical analysis
Data are the mean § SD of 3 independent experiments,
unless differently specified. The paired Student0s t-test was used
to determine the significance of the result (P < 0.05).
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